Oruka Therapeutics · 5 hours ago
Senior Scientist, Clinical Pharmacology
Oruka Therapeutics is a company focused on developing novel biologics for chronic skin diseases. They are seeking a Senior Scientist in Clinical Pharmacology to contribute to pharmacokinetic modeling and translational research efforts, aiming to develop best-in-class treatments for conditions like plaque psoriasis.
BiotechnologyHealth CareMedical
Responsibilities
Design and implement appropriate clinical modeling to contribute to successful clinical development plans and to drive rapid development
Author clinical pharmacology aspects of clinical study protocols, analysis plans, reports, and related regulatory and clinical documents
Perform non-compartmental analyses (NCA) of our clinical PK data
Influence the development of drugs and expand the application of model-informed drug development (MIDD) approaches across our portfolio. This will include the planning and execution of quantitative analyses which may include population pharmacokinetics and pharmacokinetics (PK)/pharmacodynamics (PD) exposure response
Engage with and manage outside vendors, partners and consultants as necessary, including oversight and review of PKPD analyses conducted by third party vendors
Support internal modeling and analysis outside of Clinical Pharmacology including working with Non-Clinical data and colleagues and supporting Corporate modeling efforts
Contribute to the development or improvement of our tools, processes and methodology, including involvement in internal cross-functional workgroups or initiatives, external alliances or committees, consortia and academic relationships
Manage translational research efforts associated with clinical trial objectives by working with academic collaborators
You will partner with key stakeholders and colleagues including Development teams and leaders. You will interface closely with non-clinical scientists to facilitate modeling and data analysis in the non-clinical programs
Influence and lead the external environment through scientific societies, publications, presentations, and collaborations
Qualification
Required
Bachelor's degree and 10 years of experience or master's degree and 8 years of experience in life sciences, pharmaceutical sciences, pharmacology with 8 years of experience in conducting clinical pharmacology studies including study design, PKPD data analysis, and interpretation of results
Strong quantitative experience (e.g., pharmacometrics, pharmacokinetics/pharmacodynamics, quantitative systems pharmacology, statistics)
Working knowledge of PKPD modelling approaches (including population PKPD approaches), bioanalysis, data analysis and biostatistics, programming, broad familiarity with the drug development process
Strong attention to detail with extensive experience reviewing and interpreting complex PK and PD data
Strong interpersonal skills, with the ability to work across cross-functional teams
Project management skills with sense of urgency, ability to collaborate and influence across teams
Demonstrated ability to work across functions including medical writing, clinical operations, biometrics, clinical development, quality and regulatory affairs
Excellent communication skills, both verbal and written, with the ability to convey complex data concepts to stakeholders at all levels
Preferred
PhD in Pharmaceutical Science, Math or related discipline preferred
Extensive hands-on Phoenix WinNonlin experience, R, SAS, NONMEM, or other PKPD data analysis or modeling platforms preferred
Benefits
Competitive salary and benefits package.
A chance to be part of a vibrant startup culture where your work can directly impact bringing new medicines to patients.
A supportive and inclusive team environment where everyone is encouraged to bring their authentic selves to work.
Opportunities for professional growth and development.
Company
Oruka Therapeutics
Oruka Therapeutics is advancing innovative biologics to redefine patient care standards in chronic skin diseases.
Funding
Current Stage
Public CompanyTotal Funding
$455MKey Investors
Viking Global Investors
2025-09-17Post Ipo Equity· $180M
2024-09-03Post Ipo Equity· $275M
2024-09-03IPO
Recent News
2025-12-12
Oruka Therapeutics, Inc.
2025-11-13
Company data provided by crunchbase